AI assistant
CONMED Corp — Director's Dealing 2015
Mar 5, 2015
31971_dirs_2015-03-05_ab3b2f75-42e5-4614-88ed-27a98e260f81.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2015-02-25
Reporting Person: Berge Terence M (VP Corp. Treasurer)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| 401 (K) Plan | 1231.172 | Indirect |
| Common Stock | 10531 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Rsus (restricted Stock Units) | $0 | 2020-06-01 | Common Stock (800) | Direct | |
| Rsus (restricted Stock Units) | $0 | 2020-06-01 | Common Stock (1760) | Direct | |
| Rsus (restricted Stock Units) | $0 | 2021-06-01 | Common Stock (1600) | Direct | |
| Rsus (restricted Stock Units) | $0 | 2022-06-01 | Common Stock (2400) | Direct | |
| Rsus (restricted Stock Units) | $0 | 2023-06-01 | Common Stock (3200) | Direct | |
| Rsus (restricted Stock Units) | $0 | 2024-06-01 | Common Stock (2600) | Direct | |
| Sars (Stock Appreciation Rights) | $29.92 | 2017-05-17 | Common Stock (2500) | Direct | |
| Sars (Stock Appreciation Rights) | $26.69 | 2018-06-01 | Common Stock (2500) | Direct | |
| Sars (Stock Appreciation Rights) | $16.46 | 2019-06-01 | Common Stock (2000) | Direct | |
| Sars (Stock Appreciation Rights) | $19.26 | 2020-06-01 | Common Stock (10000) | Direct | |
| Sars (Stock Appreciation Rights) | $27.63 | 2021-06-01 | Common Stock (10000) | Direct | |
| Sars (Stock Appreciation Rights) | $26.09 | 2022-06-01 | Common Stock (10000) | Direct | |
| Sars (Stock Appreciation Rights) | $32.93 | 2023-06-01 | Common Stock (10000) | Direct | |
| Sars (Stock Appreciation Rights) | $44.90 | 2024-06-01 | Common Stock (6500) | Direct |
Footnotes
F1: The 1,231.172 represent shares equivalent in a Company stock fund in the 401 (K) Plan.
F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan, with the RSUs generally vesting over a five year period with the first 20% of the RSU's vesting one year after the grant date.
F3: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan, with the RSUs vesting over a seven year period with 14% of the RSU's vesting in the first through the fifth year after the grant date and 15% vesting in the sixth and seventh year.
F4: The stock appreciation rights ("SARs") were granted under the Company's 2006 Stock Incentive Plan and generally vest in equal amounts over a five year period.
F5: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.